Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Sep 6, 2019- Beckham will serve as spokesperson and creative director for Pedialyte- Pedialyte provides advanced rehydration, with an optimal balance of electrolytes and glucose
Sep 5, 2019- TRILUMINATE Pivotal trial is the world's first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation- There are currently no approved transcatheter tricuspid repair treatments, limiting options for patients with leaky tricuspid valves who are at high risk for surgery- Abbott's TriClip tricuspid valve repair system is built on the company's proven MitraClip technology- Aug 26, 2019- The TRACK-TBI study found that 64% of people with the highest levels of a protein in the blood were confirmed to have brain injury through an MRI scan, even when a CT scan did not detect it- Abbott's diagnostic test, currently in development, is poised to be the first point-of-care blood test for assessing concussions on its next generation i-STAT™ device, providing doctors results in 15 minutes
- Aug 26, 2019- On Women's Equality Day, Abbott is publishing a blueprint for creating a high school STEM internship aimed at exposing young people, particularly girls, to STEM early and empowering other companies to download and use it- More than half of girls in a YouGov-Abbott survey say they aren't encouraged to study STEM, but 89% of girls who are urged to study STEM say they plan to pursue it in their educations
- Aug 14, 2019- Agreement gives law enforcement access to the most advanced handheld tools to help detect drug and alcohol-impaired drivers- Collaboration is a major step in keeping roads safer as recreational marijuana legalization accelerates[1]
- Jul 17, 2019- Accelerated and sustainable growth driven by strong performance across portfolio- Raising full-year guidance for organic sales growth to 7 to 8 percent- Double-digit EPS growth exceeded expectations; raising full-year forecast- Long-term growth drivers - FreeStyle Libre, MitraClip and Alinity - achieving exceptional growth
- Jul 15, 2019- U.S. approval for MitraClip G4 offers a next-generation approach to mitral valve repair- G4 includes new clip sizes and an enhanced leaflet grasping feature
- Jul 11, 2019- Alinity™ s System will screen the U.S. blood and plasma supply faster and more efficiently while maintaining highest levels of accuracy
- Jun 24, 2019- Real-world data from Advocate Health Care and Abbott shows prioritizing nutrition care for home health patients helped keep them out of the hospital- Improved health outcomes from nutrition intervention and educational support could help save millions of dollars in healthcare costs annually
-
Jun 18, 2019- Heart failure is a manageable condition, especially if it is detected early, but people are shying away from a conversation with their doctor because they are afraid of the diagnosis- Abbott, the global leader in heart failure treatment and technologies, is using this information to increase awareness and patient-physician dialogue as heart failure diagnoses are expected to rise 46% by 2030
- Jun 17, 2019- Program focused on helping people affected by conflict in Marawi City, Philippines- Chronic diseases are a critical but often overlooked problem in regions affected by disasters, conflict and other humanitarian challenges
- Jun 17, 2019- Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation- Assay is the first and only rapid point-of-care test cleared by the U.S. Food and Drug Administration (FDA) to aid healthcare professionals in the diagnosis of diabetes
- Jun 13, 2019- 45% of blood donations have historically come from people over 50 years old, but that number is declining1- As more millennials bring their passion to blood donation, they can fill the gap left by aging baby boomers- Abbott, the global leader in blood screening, is asking people of all generations to sign up to give blood and help save a life on World Blood Donor Day, June 14, and throughout the year
- Jun 8, 2019- Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has a positive impact among adults with Type 2 Diabetes who use multiple injections of insulin daily- Findings represent the first ever evaluation of real-world evidence specifically from the subset of people with Type 2 diabetes using Abbott's FreeStyle Libre system- Data underscore how actionable insights from the FreeStyle Libre system could help the more than 425 million people with diabetes1 globally make better decisions to improve diabetes management
- May 21, 2019- Late-breaking data for Abbott's investigational clip-based tricuspid heart valve repair system presented at EuroPCR- Data suggest the first-of-its-kind device reduces difficult-to-treat tricuspid regurgitation at 30 days- Study builds upon Abbott's success with its proven MitraClip™ clip-based technology in treating a similar disease on the left side of the heart
- May 16, 2019- Abbott's ZonePerfect Keto shakes and powders are formulated with a science-based macronutrient ("macros") ratio of 75% fat, 20% protein and 5% carbohydrates to support ketosis and burn body fat- ZonePerfect Keto helps fulfill a keto lifestyle on the go - offering the only true keto ready-to-drink option available nationwide at major retailers
- May 15, 2019- The YouGov-Abbott Student Loan Impact Survey shows 87% of those in college or graduating this year with student debt say finding a company with a student loan benefit is important to them- Additionally, over 6 in 10 working adults with student loans would consider switching to a company with a student loan employee benefit
- May 14, 2019- Partnership with NIH aims to increase understanding and accelerate the application of neurostimulation therapies- The BRAIN Initiative brings together the brightest minds across disciplines to improve the treatment and prevention of brain disorders
- May 6, 2019WORLD'S FIRST SMARTPHONE-COMPATIBLE IMPLANTABLE HEART MONITOR, ABBOTT'S CONFIRM Rx™ ICM OFFERS MORE ACCURATE DETECTION OF HEART RHYTHM DISORDERS
- May 2, 2019- WHO Prequalification approval allows Abbott to bring critical technology to more resource-limited settings- Confirms that the m-PIMA™ HIV-1/2 VL meets global standards of quality, safety and efficacy
- Apr 30, 2019-- Academic, military and healthcare leaders have come together to conduct a scientifically rigorous clinical trial of a blood test in development for the brain-- Research could lead to the first point-of-care blood test of its kind to help evaluate concussions within minutes
- Apr 29, 2019- Research found Abbott's High-Sensitive Troponin-I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors- Abbott's core laboratory diagnostic test is the first troponin blood test with CE Mark that can more accurately predict risk of developing heart disease, when added to other heart disease risk assessments, than using other assessments alone